Скачать или смотреть Spartan Capital Securities, LLC and B2i Digital are pleased to announce that Fractyl Health

Spartan Capital Securities, LLC and B2i Digital are pleased to announce that Fractyl Health (Nasdaq: GUTS) will be a presenting company at the upcoming Spartan Capital Investor Conference on November 3rd, 2025, in New York.

The Spartan Capital Investor Conference 2025 is a B2i Digital Featured Conference. Event details and registration for the Spartan Capital Investor Conference 2025 are available at https://b2idigital.com/spartan-capita....

Now in its second year, the conference brings together public company executive teams, institutional investors, and thought leaders from across the U.S. capital markets for strategic networking and information exchange. Taking place at the Marriott Marquis Hotel in New York, this premier event will welcome 500+ institutional and high-net-worth investors and feature presentations from 60 public and private growth companies across technology, healthcare, consumer, and other high-opportunity sectors. Attendees can expect main-stage presentations, curated one-on-one meetings, and extensive networking opportunities that connect innovative companies with sophisticated capital.

Fractyl Health is a metabolic therapeutics company focused on pioneering new approaches to the treatment of metabolic diseases, including obesity and T2D. Despite advances in treatment over the last 50 years, obesity and T2D continue to be rapidly growing drivers of morbidity and mortality in the 21st century. Fractyl’s goal is to transform metabolic disease treatment from chronic symptomatic management to durable disease-modifying therapies that target the organ-level root causes of disease. The Company has a robust and growing IP portfolio, with 33 granted U.S. patents and approximately 40 pending U.S. applications, along with numerous foreign issued patents and pending applications. Fractyl is based in Burlington, MA. For more information, visit www.fractyl.com.

Fractyl Health is led by an experienced management team including Harith Rajagopalan, M.D., Ph.D., Co-Founder and CEO (former academic cardiologist and physician-scientist from Johns Hopkins and Harvard); Jay Caplan, Co-Founder, President and Chief Product Officer (20+ years medical device leadership, former COO at Candela Corporation); Lisa Davidson, CFO and Treasurer (25+ years corporate finance experience); and Jonathan Fitzgerald, SVP of Regulatory, Quality, and Clinical (20+ years medical device startup experience).

B2i Digital is working closely with the outstanding Spartan Capital team, including John D. Lowry (CEO), Kim Monchik (CAO), Stephen Faucetta (Managing Director), and Julia Voss (Executive Assistant), to enhance each presenter’s reach through in-depth digital profiles and targeted outreach.

Investors can register to attend: https://www.meetmax.com/sched/event_1....

Learn more about Fractyl Health at https://ir.fractyl.com.